-
Defying Cancer 26.2 miles at a time
On Monday, April 21, more than 500 runners completed the 129th Boston Marathon® as part of the 2025 Dana-Farber Marathon Challenge (DFMC) team.
-
Impactful Progress: President and CEO Benjamin L. Ebert, MD, PhD, reflects on his first year and strategic vision for the future of Dana-Farber Cancer Institute
As Dana-Farber Cancer Institute marks a transformative year under the leadership of President and CEO and Susan Smith Professor of Medicine at Harvard Medical School Benjamin L. Ebert, MD, PhD, Impact spoke with him about the significant milestones achieved and the exciting path ahead.
-
Conquering blood cancers is focus of Blood Cancer United grants
Each year, nearly 200,000 Americans are diagnosed with leukemia, lymphoma, myeloma, or another bloodborne cancer. Blood Cancer United has awarded $4.2 million in grants to eight Dana-Farber physician-scientists working to better understand, treat, and potentially cure these often deadly diseases.
-
Dana-Farber faculty are part of “grand challenge” to defeat childhood tumors
Dana-Farber has been awarded more than $3 million in funding as part of a Cancer Grand Challenge to find new treatments for solid tumors in children.
-
Smith Family support inspires others to help speed multiple myeloma research
Paul Richardson has found an important partner in Robert and Dana Smith, who recently made a $3 million gift to continue supporting his advanced MM clinical trials research.
-
Advancing early detection research through the Larry and Susan Marx Fund
Larry and Susan Marx established the Larry and Susan Marx Fund for Early Detection with a $2.6 million gift, supporting efforts to detect and screen cancers earlier and improve treatment outcomes.
-
A home run for hope: A Father’s tribute advances pediatric research
The late Robert P. Cingolani, DPM—affectionately known as “Doc”—was a dedicated physician, devoted father, and cherished community member. He made a transformative $2 million estate gift to support pediatric cancer research at Dana-Farber Cancer Institute in memory of his son, Michael, who passed away from bone cancer at the age of 19.
-
Russ Agrusa honors late wife by fueling colorectal cancer research
Russ and his late wife, Paula, established the Project P Fund in 2014 with a goal of empowering researchers at Dana-Farber to develop more effective targeted and immune-based therapies for patients with colorectal cancer. Since Paula’s death in 2016, Russ has continued to honor her legacy through ongoing support for the Project P Fund. With…
-
Transformational gift expands international fellowships in breast oncology
Over the past 13 years, the Goldfarb and Rudkin Family International Fellowships in Breast Oncology at Dana-Farber Cancer Institute have accelerated scientific breakthroughs, fostered career growth through mentorship and collaboration, and advanced cancer care for patients around the world.
-
Susan G. Komen strengthens commitment to breast cancer research
In 2024, Komen reaffirmed its dedication to Dana-Farber Cancer Institute by awarding three new Career Transition Awards totaling $1.95 million, alongside 12 active research grants. This investment underscores Komen's ongoing support for groundbreaking studies and improving outcomes for those affected by breast cancer.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.